semaglutide hf in Patients with Heart Failure with Preserved Ejection Fraction and Obesity A big STEP for treatment

In Phase 3 TRIUMPH-4, retatrutide at 12 mg produced 28.7% body weight loss at 68 weeks vs 2.1% for placebo

May cause injection site reactions Some patients may experience mild reactions such as redness, swelling, itching, etc

Since compounded semaglutide contains other ingredients like vitamin B12, improper storage can cause more noticeable changes in its color, clarity, and possibly separation

If your clinician finds thyroid dysfunction, insulin resistance, or chronic inflammation driving your weight gain, we address those alongside GLP-1 therapy

If you notice that your blood sugar levels are not as well controlled as before, or if you experience increased hunger or tiredness, let your doctor know

After a thorough initial consultation, we will recommend a specific program and closely monitor you to ensure optimal results while maintaining safety